Aidan Dunphy
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 6
-
- Frailty in Older Adults 1
- Journals
- The Lancet (6 papers)SHURA (Sheffield Hallam University Research Archive) (Sheffield Hallam University) (1 paper)
- Partner nations
- United KingdomVietnamNepal
In The Last Decade
Aidan Dunphy
8 papers receiving 1.6k citations
Aidan Dunphy's Hit Papers
Peers
Comparison fields: 5 of 89
- Infectious Diseases 1.3k
- Applied Microbiology and Biotechnology 35
- Internal Medicine 27
- Statistics and Probability 45
- Oncology 75
Countries citing papers authored by Aidan Dunphy
This map shows the geographic impact of Aidan Dunphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aidan Dunphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aidan Dunphy more than expected).
Fields of papers citing papers by Aidan Dunphy
This network shows the impact of papers produced by Aidan Dunphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aidan Dunphy. The network helps show where Aidan Dunphy may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 5 | 2021 | 213 | |
| 6 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 7 | NHS Outcomes Framework 2012–13 | 2015 | 32 |
| 8 | 2015 | 10 |
About Aidan Dunphy
Aidan Dunphy is a scholar working on Infectious Diseases, Geriatrics and Gerontology, General Health Professions, Emergency Medicine and Health Information Management, having authored 8 papers that have together received 1.7k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Health Services Management and Policy (1 paper), Hospital Admissions and Outcomes (1 paper), Geriatric Care and Nursing Homes (1 paper), Healthcare Quality and Management (1 paper) and Frailty in Older Adults (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Applied Microbiology and Biotechnology (35 citations), Internal Medicine (27 citations), Statistics and Probability (45 citations) and Oncology (75 citations). Aidan Dunphy has collaborated with scholars based in United Kingdom, Vietnam and Nepal. Their work appears in journals such as The Lancet and SHURA (Sheffield Hallam University Research Archive) (Sheffield Hallam University).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.